Literature DB >> 25649511

Regulatory biocompatibility requirements for biomaterials used in regenerative medicine.

David F Williams1.   

Abstract

The biological safety of biomaterials used for implantable medical devices is usually determined by a series of standard tests that assess the effects that extractable substances have on cells in vitro and in simple short term animal studies. To use these tests to determine the suitability of materials for tissue engineering templates is inappropriate. This short essay discusses the issues that are involved.

Mesh：

Substances：

Year:  2015        PMID： 25649511     DOI： 10.1007/s10856-015-5421-7

Source DB:  PubMed          Journal:  J Mater Sci Mater Med        ISSN： 0957-4530            Impact factor:   3.896


  4 in total

1.  To engineer is to create: the link between engineering and regeneration.

Authors:  David F Williams
Journal:  Trends Biotechnol       Date:  2005-11-10       Impact factor: 19.536

Review 2.  On the mechanisms of biocompatibility.

Authors:  David F Williams
Journal:  Biomaterials       Date:  2008-04-28       Impact factor: 12.479

Review 3.  The biomaterials conundrum in tissue engineering.

Authors:  David F Williams
Journal:  Tissue Eng Part A       Date:  2014-02-14       Impact factor: 3.845

4.  There is no such thing as a biocompatible material.

Authors:  David F Williams
Journal:  Biomaterials       Date:  2014-09-26       Impact factor: 12.479
  4 in total
  1 in total

1.  Differences in cytocompatibility, dynamics of the oxide layers' formation, and nickel release between superelastic and thermo-activated nickel-titanium archwires.

Authors:  Miodrag Čolić; Sergej Tomić; Rebeka Rudolf; Evgenija Marković; Ivana Šćepan
Journal:  J Mater Sci Mater Med       Date:  2016-06-30       Impact factor: 3.896
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.